Journalartikel
Autorenliste: Albrecht, K.; Mueller-Ladner, U.
Jahr der Veröffentlichung: 2010
Seiten: S95-S101
Zeitschrift: Clinical and Experimental Rheumatology
Bandnummer: 28
Heftnummer: 5
ISSN: 0392-856X
Verlag: Clinical and Experimental Rheumatology Sas
Abstract:
Low-dose methotrexate (MTX) remains the first-line treatment option among the disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. However, diverse side effects are the major reason for MTX withdrawal and change of treatment. The following article reviews the published data on general and organ-specific side effects and outlines the current recommendations addressing prevention and management of MTX-associated adverse effects.
Zitierstile
Harvard-Zitierstil: Albrecht, K. and Mueller-Ladner, U. (2010) Side effects and management of side effects of methotrexate in rheumatoid arthritis, Clinical and Experimental Rheumatology, 28(5), pp. S95-S101
APA-Zitierstil: Albrecht, K., & Mueller-Ladner, U. (2010). Side effects and management of side effects of methotrexate in rheumatoid arthritis. Clinical and Experimental Rheumatology. 28(5), S95-S101.
Schlagwörter
ACCELERATED NODULOSIS; CLINICAL-PRACTICE; Expert opinion; FOLINIC ACID; LIVER TOXICITY; LOW-DOSE METHOTREXATE; METHOTREXATE; OF-THE-LITERATURE; PUBLISHED EVIDENCE; Side effects
